Therefore, the present study addresses ischemia-associated changes of MBP, CNP, laminin, and collagen IV to investigate the impact of different methodological aspects including the choice of antibody clonality and tissue pre-treatment used for immunofluorescence labeling in comparison to Western blotting in a mouse model of permanent focal cerebral ischemia. The gene discussed is CNP; the disease is ischemia.